Company
Advent Life Sciences
Investments
| Company | Round | Date | Lead |
|---|---|---|---|
| Relief Cardiovascular | Series A | 2025-01-08 | Lead |
| Moximed | Series D Financing | 2024-08-14 | |
| Artax Biopharma | Convertible Debt Funding | 2024-08-06 | |
| PIC Therapeutics | Series A | 2022-10-20 |
Company
| Company | Round | Date | Lead |
|---|---|---|---|
| Relief Cardiovascular | Series A | 2025-01-08 | Lead |
| Moximed | Series D Financing | 2024-08-14 | |
| Artax Biopharma | Convertible Debt Funding | 2024-08-06 | |
| PIC Therapeutics | Series A | 2022-10-20 |